Astex Pharmaceuticals, Inc.
astx.comTotal trials
45
Active
0
Phase 3
9
Total enrollment
3,753
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Acute Myeloid Leukemia7
- Myelodysplastic Syndromes5
- Pancreatic Cancer4
- Chronic Myelogenous Leukemia3
- Healthy Volunteer2
- Myelodysplastic Syndrome2
- MDS2
- Prostate Cancer2
Frequently asked questions about Astex Pharmaceuticals, Inc.
- How many clinical trials does Astex Pharmaceuticals, Inc. have on ClinicalTrials.gov?
- Astex Pharmaceuticals, Inc. is listed as the lead sponsor on 45 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Astex Pharmaceuticals, Inc.'s trials are in Phase 3?
- 9 of Astex Pharmaceuticals, Inc.'s trials are in Phase 3.
- What therapeutic areas does Astex Pharmaceuticals, Inc. focus on?
- Astex Pharmaceuticals, Inc.'s most-studied conditions on ClinicalTrials.gov are Acute Myeloid Leukemia, Myelodysplastic Syndromes, Pancreatic Cancer, Chronic Myelogenous Leukemia, Healthy Volunteer.